PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis b |
| Symptom | |liver disease |
| Sentences | 65 |
| PubMedID- 22537436 | Noninvasive methods to assess liver disease in patients with hepatitis b or c. |
| PubMedID- 21055694 | Morphologic aspects of liver disease associated with hepatitis b and c viruses, autoimmune hepatitis, and hiv infection were addressed, as was the prevalent problem of nonalcoholic fatty liver disease. |
| PubMedID- PMC3315908 | liver disease due to chronic hepatitis b and c is now a leading cause of mortality among hiv-infected patients in the developed world. |
| PubMedID- 24693307 | Non-invasive histologic markers of liver disease in patients with chronic hepatitis b. |
| PubMedID- 24533061 | , in brief, the 2013 who guidelines recommend that haart eligibility be expanded to all hiv infected individuals regardless of symptoms if they have a cd4 cell count of less than 500/mm3, or regardless of cd4 count level if there is tb co-infection, or liver disease due to hepatitis b virus co-infection, or for individuals at very high risk for hiv transmission, such as sero-discordant couples and pregnant hiv infected women, who are encouraged to start haart during pregnancy and continue lifelong therapy thereafter, and for children infected with hiv under the age of 5 years old who are also advised to continue lifelong therapy. |
| PubMedID- 22760654 | liver disease due to chronic hepatitis b virus (hbv) and hepatitis c virus (hcv) infection is now emerging as an increasing cause of morbidity and mortality in human immunodeficiency virus- (hiv-) infected persons in resource-limited settings (rls). |
| PubMedID- 21191876 | Low response rate to a vaccination against hepatitis b in patients with end-stage liver disease. |
| PubMedID- 21331379 | Tlr-mediated signals result in liver disease associated with hepatitis b, hepatitis c, alcoholicnonalcoholic steatohepatitis, and hepatic fibrosis . |
| PubMedID- 24504013 | A survey conducted by the centers for disease control shows that there are over 5 million individuals in the united states who suffer from liver disease associated with hepatitis b.71 when faced with the challenge of combating viral infections of endemic or epidemic proportions, new knowledge of the mechanisms used by viruses to evade the host antiviral response may prove to be indispensable in more efficient vaccine design and drug development. |
| PubMedID- 23827008 | In many countries, the burden of chronic liver disease due to hepatitis b and c is increasing due to ageing of unvaccinated populations and migration, and a probable increase in drug injecting. |
| PubMedID- 21194431 | The underlying etiology of liver disease was attributed to hepatitis b virus (hbv) infection if patients were seropositive for hepatitis b surface antigen (hbsag, ria kits, abbott laboratories, north chicago, il, usa) and attributed to hepatitis c virus (hcv) infection if patients were seropositive for an antibody against hcv by a second-generation enzyme immunoassay (abbott laboratories, il). |
| PubMedID- 25266850 | Additionally, test and treat is recommended for selected groups of hiv-positive individuals, namely, (a) people with tuberculosis in 58 countries, (b) pregnant women in 42 countries, (c) people with liver disease due to hepatitis b co-infection in 52 countries, (d) serodiscordant couples in 35 countries and (e) children below 5 years in nine countries. |
| PubMedID- 22980664 | Expression of mcp-1 in the patients of chronic hepatitis b complicated with nonalcoholic fatty liver disease. |
| PubMedID- 22989301 | Background and aim: non-alcoholic fatty liver disease (nafld) overlapping with chronic hepatitis b virus (hbv) infection is undergoing a rapid increase in china. |
| PubMedID- 25532128 | The mechanisms whereby hdv leads to accelerated liver disease in hepatitis b virus (hbv)/hdv co-infected patients and the histological characteristics of chronic hepatitis d (chd) patients need further investigation. |
Page: 1 2